A share price of Sera Prognostics Inc [SERA] is currently trading at $9.94, up 2.47%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The SERA shares have gain 7.93% over the last week, with a monthly amount glided 4.30%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 20, March 2024, SERA PROGNOSTICS REPORTS FOURTH QUARTER 2023 FINANCIAL RESULTS. In a post published today on Yahoo Finance, Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the fourth quarter and full year ended December 31, 2023.
From an analyst’s perspective:
Sera Prognostics Inc [NASDAQ: SERA] stock has seen the most recent analyst activity on March 30, 2022, when Citigroup downgraded its rating to a Neutral and also revised its price target to $4 from $18. Previously, Oppenheimer started tracking the stock with Outperform rating on November 19, 2021, and set its price target to $19.
Sera Prognostics Inc experienced fluctuations in its stock price throughout the past year between $1.52 and $10.44. Sera Prognostics Inc [NASDAQ: SERA] shares were valued at $9.94 at the most recent close of the market.
Analyzing the SERA fundamentals
Trailing Twelve Months sales for Sera Prognostics Inc [NASDAQ:SERA] were 0.31M which represents -36.92% decline. Gross Profit Margin for this corporation currently stands at -0.38% with Operating Profit Margin at -129.81%, Pretax Profit Margin comes in at -118.44%, and Net Profit Margin reading is -115.99%. To continue investigating profitability, this company’s Return on Assets is posted at -0.37, Equity is -0.45 and Total Capital is -0.56. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.58 points at the first support level, and at 9.23 for the second support level. However, for the 1st resistance point, the stock is sitting at 10.19, and for the 2nd resistance point, it is at 10.45.
Sera Prognostics Inc [SERA] reported earnings per share of -$0.25 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.26/share, meaning a difference of $0.01 and a surprise factor of 3.80%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.23 per share as compared to estimates of -$0.34 per share, a difference of $0.11 representing a surprise of 32.40%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Sera Prognostics Inc [NASDAQ:SERA] is 2.51. Also, the Quick Ratio is 2.51, while the Cash Ratio stands at 0.16. Considering the valuation of this stock, the price to sales ratio is 1039.85, the price to book ratio is 4.49.
Transactions by insiders
Recent insider trading involved Boniface John J., Chief Scientific Officer, that happened on Mar 28 ’24 when 24474.0 shares were sold. Chief Scientific Officer, Boniface John J. completed a deal on Mar 27 ’24 to sell 52662.0 shares. Meanwhile, Chief Executive Officer Lindgardt Zhenya sold 38899.0 shares on Mar 26 ’24.
